Jan de Witte - 25 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Director
Issuer ticker: RMD
Reported as of: 25 Nov 2025
Net transaction value: -$524,025
SEC form: 4
Accepted by SEC: 26 Nov 2025, 14:40:00 UTC
Prior SEC filing: 24 Nov 2025
Source filing: View source filing
Reporting owner signature: Jan De Witte, director

Key filing fact

Jan de Witte filed Form 4 for RESMED INC (RMD) on 26 Nov 2025.

Key facts

This page summarizes Jan de Witte's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Nov 2025, 14:40.

Change

Previous filing in this sequence was filed on 24 Nov 2025.
Current net transaction value: -$524,025.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001776929 Primary reporting owner

De Witte Jan

Relationship: Director
Address: 9001 SPECTRUM CENTER BLVD., C/O RESMED INC, SAN DIEGO
Signature: Jan De Witte, director
Signature date: 26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ReMed Common Stock

Sale

Transaction value: $524,025
Shares: -2,055
Change %: -33%
Price: $255.00
Shares after: 4,261
Date: 25 Nov 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The transaction was conducted under a Rule 10b5-1 plan adopted on August 18, 2025.